We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Medgenics Names Clarence “Butch” Dellio as Chief Operating Officer

News   Jul 06, 2011

 
Medgenics Names Clarence “Butch” Dellio as Chief Operating Officer
 
 
 

RELATED ARTICLES

New Study of HIV Vaccine Shows Promising Results Across Strains

News

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.

READ MORE

Discontinuing Oral Immunotherapy for Peanut Allergy Reduces Its Protective Effects

News

A study has followed participants after oral immunotherapy (OIT) for peanut allergy have found that discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects.

READ MORE

B Cells May Be More Important in Immunotherapy Than Previously Thought

News

Researchers have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE